Sadhana Nitro Chem Ltd
Incorporated in 1973, Sadhana Nitro Chem Ltd manufactures chemical intermediates, heavy organic chemicals performance chemicals, and wireless network equipment and services[1]
- Market Cap ₹ 732 Cr.
- Current Price ₹ 2.45
- High / Low ₹ 5.88 / 1.27
- Stock P/E
- Book Value ₹ 1.53
- Dividend Yield 4.08 %
- ROCE -11.1 %
- ROE -23.5 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Promoter holding has increased by 30.9% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -13.6% over past five years.
- Company has a low return on equity of -8.82% over last 3 years.
- Company has high debtors of 977 days.
- Company's cost of borrowing seems high
- Promoter holding has decreased over last 3 years: -13.1%
- Working capital days have increased from 354 days to 734 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48 | 36 | 55 | 114 | 267 | 106 | 103 | 132 | 143 | 190 | 166 | 50 | |
| 52 | 34 | 47 | 79 | 147 | 77 | 80 | 117 | 122 | 149 | 123 | 103 | |
| Operating Profit | -4 | 2 | 8 | 35 | 120 | 29 | 23 | 15 | 21 | 41 | 42 | -53 |
| OPM % | -8% | 5% | 15% | 31% | 45% | 27% | 23% | 11% | 15% | 22% | 26% | -107% |
| 14 | 0 | 0 | 0 | 1 | 2 | 5 | 5 | 2 | 4 | 2 | 9 | |
| Interest | 5 | 5 | 6 | 5 | 12 | 3 | 3 | 5 | 10 | 17 | 18 | 26 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 6 | 6 | 6 | 8 | 15 | 15 | 16 |
| Profit before tax | 3 | -5 | 1 | 28 | 107 | 22 | 19 | 9 | 6 | 13 | 12 | -87 |
| Tax % | -35% | 0% | 0% | -11% | 29% | 34% | 15% | 30% | 44% | 68% | 34% | -1% |
| 4 | -5 | 1 | 31 | 76 | 15 | 16 | 6 | 3 | 4 | 8 | -86 | |
| EPS in Rs | 0.01 | -0.02 | 0.00 | 0.11 | 0.26 | 0.05 | 0.06 | 0.02 | 0.01 | 0.01 | 0.03 | -0.29 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 47% | 95% | 91% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -14% |
| 3 Years: | -30% |
| TTM: | -70% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1243% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | -16% |
| 3 Years: | -53% |
| 1 Year: | -56% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -6% |
| 3 Years: | -9% |
| Last Year: | -24% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 14 | 20 | 20 | 25 | 33 | 296 |
| Reserves | -7 | -12 | 1 | 37 | 96 | 107 | 116 | 141 | 206 | 202 | 248 | 158 |
| 37 | 44 | 36 | 16 | 8 | 46 | 83 | 116 | 139 | 233 | 247 | 113 | |
| 26 | 27 | 37 | 78 | 64 | 53 | 91 | 110 | 61 | 73 | 109 | 90 | |
| Total Liabilities | 66 | 68 | 83 | 139 | 177 | 216 | 304 | 386 | 426 | 532 | 637 | 658 |
| 31 | 29 | 37 | 50 | 76 | 84 | 78 | 75 | 144 | 156 | 150 | 163 | |
| CWIP | 9 | 9 | 9 | 11 | 2 | 15 | 23 | 68 | 28 | 53 | 100 | 78 |
| Investments | 0 | 0 | 0 | 0 | 5 | 6 | 6 | 7 | 6 | 6 | 0 | 0 |
| 26 | 30 | 37 | 78 | 94 | 111 | 197 | 236 | 248 | 317 | 387 | 416 | |
| Total Assets | 66 | 68 | 83 | 139 | 177 | 216 | 304 | 386 | 426 | 532 | 637 | 658 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 | -1 | 9 | 35 | 53 | -17 | 1 | -5 | -38 | -3 | 54 | -29 | |
| -0 | -0 | -1 | -6 | -25 | -22 | -23 | -39 | -53 | -65 | -89 | -46 | |
| -9 | 2 | -25 | -13 | -23 | 30 | 30 | 46 | 72 | 42 | 25 | 93 | |
| Net Cash Flow | 0 | 1 | -16 | 16 | 5 | -9 | 7 | 2 | -19 | -26 | -10 | 18 |
| Free Cash Flow | 9 | -1 | 8 | 29 | 32 | -39 | -7 | -46 | -86 | -68 | -39 | -93 |
| CFO/OP | -246% | -47% | 110% | 107% | 51% | 4% | 5% | 23% | -154% | -4% | 121% | 50% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56 | 131 | 68 | 49 | 21 | 100 | 173 | 113 | 167 | 242 | 270 | 977 |
| Inventory Days | 102 | 176 | 222 | 184 | 217 | 600 | 600 | 641 | ||||
| Days Payable | 226 | 395 | 350 | 195 | 64 | 254 | 234 | 314 | ||||
| Cash Conversion Cycle | -68 | -88 | -59 | 37 | 174 | 446 | 539 | 113 | 167 | 242 | 270 | 1,304 |
| Working Capital Days | -211 | -321 | -127 | -107 | 24 | 69 | 95 | 71 | 207 | 179 | 150 | 734 |
| ROCE % | -13% | 0% | 16% | 62% | 136% | 18% | 12% | 6% | 5% | 7% | 6% | -11% |
Insights
In beta| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Sales Percentage % ・Standalone data |
|
|||||||||||
| Number of Employees Number ・Standalone data |
||||||||||||
| Meta Amino Phenol (MAP) Installed Capacity TPA |
||||||||||||
| ODB2 Installed Capacity TPA |
||||||||||||
| Nitrobenzene (NB) Installed Capacity TPA |
||||||||||||
| Para Amino Phenol (PAP) Installed Capacity TPA |
||||||||||||
| Energy Intensity GJ/MT |
||||||||||||
| Exported Chemicals MT |
||||||||||||
| Water Intensity KL/MT |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement Under Regulation 30 (LODR) - Issue And Allotment Of 6,75,00,000 Equity Shares Having Face Value Of Re. 1 Each On A Preferential Basis
2d - 6.75 crore preferential shares allotted at ₹2.06, floor price ₹2.05.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual secretarial compliance report for FY ended 31 March 2026 notes multiple LODR violations and fines.
-
Announcement Under Regulation 30 (LODR) - Long Term Supply Contract
28 May - Signed two-year Japanese export supply contract worth about Rs. 108 crore; order book exceeds Rs. 200 crore.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Copies of Newspaper publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026 in Financial Express and Mumbai …
-
Statement Of Deviation Or Variation Of Funds Utilised Through The Rights Issue For The Quarter Ended March 31, 2026
26 May - No deviation in use of Rs. 263.53 crore rights issue proceeds for quarter ended March 31, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
SNCL is an ISO 9001:2015 certified and a government-recognized 2-Star Golden Export House. It is in the business of chemical and chemical products, pharma, medicinal chemicals, and intermediates